Association of TNF-1031T/C and clinical efficacy of insulin therapy in newly diagnosed type 2 diabetics

National Medical Journal of China

Volumn 93, Issue 40, 2013, Pages 3197-3201

  Xu, Hai Xia ^a   Xu, Wen ^a   Xu, Fen ^a   Liang, Hua ^a   Yan, Jin Hua ^a   Chen, Zhi Peng ^b   Sun, Yi Ting ^b   Yao, Bin ^a   Weng, Jian Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b NONE

Author keywords

Diabetes mellitus, type 2; Insulin; Polymorphism, single nucleotide; Tumor necrosis factor alpha

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO; LIPID; TUMOR NECROSIS FACTOR;

ALLELE; ARTICLE; CASE CONTROL STUDY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; FOLLOW UP; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TREATMENT; LIPID COMPOSITION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; INSULIN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887283547     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.40.008     Document Type: Article

References (17)

1. Mirza S, Hossain M, Mathews C, et al. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine, 2012, 57: 136-142.
2. 2007, 23: 134-138.
3. Hu Y, Li L, Xu Y, et al. Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and beta-cell function in subjects with long-term remission. Diabetes care, 2011, 34: 1848-1853.
4. Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet, 2008, 371: 1753-1760.
5. Uysal K T, Wiesbrock S M, Marino M W, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature, 1997, 389: 610-614.
6. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens, 1998, 51: 605-612.
7. Li Z, Zhang Z, He Z, et al. Apartition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res, 2009, 19: 519-523.
8. Donath M Y, Shoelson S E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 2011, 11: 98-107.
9. Feng R N, Zhao C, Sun C H, et al. Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus. PloS One, 2011, 6: e18480.
10. Boraska V, Rayner N W, Groves C J, et al. Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med Genet, 2010, 11: 69.
11. Kamizono S, Yamada K, Seki N, et al. Susceptible locus for obese type 2 diabetes mellitus in the 5'-flanking region of the tumor necrosis factor-alpha gene. Tissue antigens, 2000, 55: 449-452.
12. Skoog T, van't Hooft F M, Kallin B, et al. A common functional polymorphism (C-- > A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet, 1999, 8: 1443-1449.
13. Akman A, Sallakci N, Coskun M, et al. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br J Dermatol, 2006, 155: 350-356.
14. Cay H F, Sezer I, Dogan S, et al. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjogren's syndrome. Clin Exp Rheumatol, 2012, 30: 843-849.
15. Mishra N, Arankalle V A. Association of polymorphisms in the promoter regions of TNF-alpha (-308) with susceptibility to hepatitis E virus and TNF-alpha (-1031) and IFN-gamma (+874) genes with clinical outcome of hepatitis E infection in India. J Hepatol, 2011, 55: 1227-1234.
16. Tong Q, Zhao D B, Bajracharya P, et al. TNF-alpha -857 and -1031 polymorphisms predict good therapeutic response to TNF-alpha blockers in Chinese Han patients with ankylosing spondylitis. Pharmacogenomics, 2012, 13: 1459-1467.
17. Xu W, Li Y B, Deng W P, et al. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study. Chin Med J, 2009, 122: 2554-2559.